The aim of this work is to analyse the consistency between demand, on the one hand, and good practice guidelines and the views of professionals on the other, with a view to including gene amplification (PCR) for the cytomegalovirus (CMV), herpes simplex virus (HSV) and varicella-zoster virus (VZV) through genetic amplification in the diagnosis and treatment of opportunistic diseases in people living with HIV on the list of clinical laboratory procedures reimbursed by the National Health Insurance system in France
See also
HAS opinions and decisions
29/01/2016
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
X7ga0Dw2NCZTrXDB